Has a 3-fold decreased dose of Bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial

1. Martínez-Piñeiro, J.A.
2. Martínez-Piñeiro, L.
3. Solsona, E.
4. Hernández Rodríguez, R.
5. Fernández Gómez, J.M.
6. González Martín, M.
7. Rodríguez Molina, J.
8. Gimeno Collado, A.
9. Flores, N.
10. Isorna, S.
11. Pertusa, C.
12. Rabadán, M.
13. Astobieta, A.
14. Camacho, J.E.
15. Arribas, S.
16. Madero, R.